20 related articles for article (PubMed ID: 9635414)
1. TRAPnSeq allows high-throughput profiling of antigen-specific antibody-secreting cells.
Asrat S; Devlin JC; Vecchione A; Klotz B; Setliff I; Srivastava D; Limnander A; Rafique A; Adler C; Porter S; Murphy AJ; Atwal GS; Sleeman MA; Lim WK; Orengo JM
Cell Rep Methods; 2023 Jul; 3(7):100522. PubMed ID: 37533642
[TBL] [Abstract][Full Text] [Related]
2. PD-L1 Blockade During Allergen Sensitization Inhibits the Synthesis of Specific Antibodies and Decreases Mast Cell Activation in a Murine Model of Active Cutaneous Anaphylaxis.
Bonamichi-Santos R; Aun MV; Kalil J; Castells MC; Giavina-Bianchi P
Front Immunol; 2021; 12():655958. PubMed ID: 33968057
[TBL] [Abstract][Full Text] [Related]
3. The transcription factors GATA2 and microphthalmia-associated transcription factor regulate Hdc gene expression in mast cells and are required for IgE/mast cell-mediated anaphylaxis.
Li Y; Liu B; Harmacek L; Long Z; Liang J; Lukin K; Leach SM; O'Connor B; Gerber AN; Hagman J; Roers A; Finkelman FD; Huang H
J Allergy Clin Immunol; 2018 Oct; 142(4):1173-1184. PubMed ID: 29277702
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of three novel Radix Scutellariae extracts on immediate hypersensitivity.
Li X; Wang J; Shi H; Gao L; Wang X
Afr J Tradit Complement Altern Med; 2014; 11(5):54-60. PubMed ID: 25395705
[TBL] [Abstract][Full Text] [Related]
5. Measuring local anaphylaxis in mice.
Evans H; Killoran KE; Mitre E
J Vis Exp; 2014 Oct; (92):e52005. PubMed ID: 25350839
[TBL] [Abstract][Full Text] [Related]
6. Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 2. Efficacy studies in allergic and pulmonary inflammation models in vivo.
Stenton GR; Mackenzie LF; Tam P; Cross JL; Harwig C; Raymond J; Toews J; Chernoff D; MacRury T; Szabo C
Br J Pharmacol; 2013 Mar; 168(6):1519-29. PubMed ID: 23121409
[TBL] [Abstract][Full Text] [Related]
7. Quantitative evaluation of passive cutaneous anaphylaxis (PCA) using a hand-held spectrophotometer.
Akiyama H; Teshima R; Akasaka R; Fujimori K; Goda Y; Sawada J; Toyoda M
Biol Pharm Bull; 1996 Aug; 19(8):1112-4. PubMed ID: 8874831
[TBL] [Abstract][Full Text] [Related]
8. Active cutaneous anaphylaxis (ACA) in the mouse ear.
Inagaki N; Miura T; Nagai H; Koda A
Jpn J Pharmacol; 1992 Jun; 59(2):201-8. PubMed ID: 1434116
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of IgG1 and IgE antibody mediated homologous PCA in the mouse ear. Lack of cross-desensitization of IgG1 antibody mediated PCA to IgE antibody mediated PCA.
Inagaki N; Nagai H; Koda A
Int Arch Allergy Appl Immunol; 1988; 86(3):325-30. PubMed ID: 3403047
[TBL] [Abstract][Full Text] [Related]
10. Orally supplemented Lactobacillus acidophilus strain L-92 inhibits passive and active cutaneous anaphylaxis as well as 2,4-dinitroflurobenzene and mite fecal antigen induced atopic dermatitis-like skin lesions in mice.
Shah MM; Miyamoto Y; Yamada Y; Yamashita H; Tanaka H; Ezaki T; Nagai H; Inagaki N
Microbiol Immunol; 2010 Sep; 54(9):523-33. PubMed ID: 20840151
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of 1.5-hour and 48-hour homologous passive cutaneous anaphylaxis in the mouse ear.
Inagaki N; Nagai H; Nakatomi I; Koda A
J Pharmacobiodyn; 1988 Jan; 11(1):31-8. PubMed ID: 2455035
[TBL] [Abstract][Full Text] [Related]
12. Simple spectrophotometric analysis of passive and active ear cutaneous anaphylaxis in the mouse.
Teshima R; Akiyama H; Akasaka R; Goda Y; Toyoda M; Sawada J
Toxicol Lett; 1998 Mar; 95(2):109-15. PubMed ID: 9635414
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
